Breast cancer (BC) is one of the major causes of poor health in women and the most devastating
disease after lung cancer. The term "cancer" refers to a collection of problems resulting from abnormal cell
proliferation, particularly cells that can spread to other parts of the body. Surgery, followed by chemotherapy
or radiotherapy, is now accepted for BC-related cancers. However, chemotherapy and radiotherapy are rarely
effective in the treatment of BC due to the adverse effects of these treatments on healthy tissues and organs.
Consequently, the use of NPs in targeted Drug Delivery Systems (DDSs) has emerged as a promising strategy
for BC treatment. This review provides a summary of recent clinical investigations of nanoparticle-mediated
DDS that offer a novel therapeutic strategy commonly used for the treatment of breast cancer.